Workshop Synopsis

This workshop has been developed in response to the growing recognition that increasing the efficiency and effectiveness of the pharmacometric analysis process is a critical prerequisite for the successful transition to model -based drug development. The mutually dependent goals of commercial and regulatory success will require an emphasis on the reliable delivery of timely information at critical milestones. Achieving these goals will require new skills in corporate leadership, technical prowess, and new levels of cooperation and communication across departments to successfully implement (or strengthen) the pharmacometric process and its interface with the larger drug development enterprise.